You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 163 No. 13, July 14, 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Drug Therapy
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Harbinger of Fluoroquinolone Resistance

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The recent article by Lautenbach et al1 has raised concerns regarding the emerging problem of fluoroquinolone antibiotic resistance, and most important, demonstrates the potential gravity of fluoroquinolone overuse. We concur that strategies to reduce inappropriate fluoroquinolone utilization are clearly important. However, little is known whether the recent rise in fluoroquinolone resistance is related to increasing prescription rate as influenced by the industrial advertisements.

Given the fact that primary care physicians receive medical journals with the most advertisements,2 we evaluated the patterns of pharmaceutical advertisements for antibiotics in 4 major journals targeted for family practitioners (American Family Physician, Canadian Family Physician, Journal of Family Practice, and Postgraduate Medicine). We confined our survey of pharmaceutical advertisements to antibacterial agents. To account for monthly variations in advertising budgets, we randomly selected 4 months (January, April, July, and October) for each journal between calendar years 1984 and 2002. Among . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Fluoroquinolone Utilization in the Emergency Departments of Academic Medical Centers: Prevalence of, and Risk Factors for, Inappropriate Use
Ebbing Lautenbach, Lori A. Larosa, Nishaminy Kasbekar, Helen P. Peng, Richard J. Maniglia, and Neil O. Fishman
Arch Intern Med. 2003;163(5):601-605.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.